1. Home
  2. INZY vs CPBI Comparison

INZY vs CPBI Comparison

Compare INZY & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • CPBI
  • Stock Information
  • Founded
  • INZY 2015
  • CPBI 2023
  • Country
  • INZY United States
  • CPBI United States
  • Employees
  • INZY N/A
  • CPBI N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • CPBI
  • Sector
  • INZY Health Care
  • CPBI
  • Exchange
  • INZY Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • INZY 64.9M
  • CPBI 58.1M
  • IPO Year
  • INZY 2020
  • CPBI N/A
  • Fundamental
  • Price
  • INZY $3.97
  • CPBI $14.55
  • Analyst Decision
  • INZY Buy
  • CPBI
  • Analyst Count
  • INZY 9
  • CPBI 0
  • Target Price
  • INZY $15.22
  • CPBI N/A
  • AVG Volume (30 Days)
  • INZY 5.3M
  • CPBI 1.3K
  • Earning Date
  • INZY 05-14-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • INZY N/A
  • CPBI N/A
  • EPS Growth
  • INZY N/A
  • CPBI 29.70
  • EPS
  • INZY N/A
  • CPBI 1.62
  • Revenue
  • INZY N/A
  • CPBI $18,546,000.00
  • Revenue This Year
  • INZY N/A
  • CPBI N/A
  • Revenue Next Year
  • INZY N/A
  • CPBI N/A
  • P/E Ratio
  • INZY N/A
  • CPBI $9.00
  • Revenue Growth
  • INZY N/A
  • CPBI 13.73
  • 52 Week Low
  • INZY $0.72
  • CPBI $9.96
  • 52 Week High
  • INZY $6.24
  • CPBI $15.50
  • Technical
  • Relative Strength Index (RSI)
  • INZY 85.93
  • CPBI 43.62
  • Support Level
  • INZY $3.94
  • CPBI $14.53
  • Resistance Level
  • INZY $3.97
  • CPBI $14.80
  • Average True Range (ATR)
  • INZY 0.08
  • CPBI 0.10
  • MACD
  • INZY 0.12
  • CPBI -0.04
  • Stochastic Oscillator
  • INZY 99.32
  • CPBI 4.26

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.

Share on Social Networks: